These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8077054

  • 1. Characterization of a human bladder cancer cell line selected for resistance to mitomycin C.
    Xu BH, Gupta V, Singh SV.
    Int J Cancer; 1994 Sep 01; 58(5):686-92. PubMed ID: 8077054
    [Abstract] [Full Text] [Related]

  • 2. Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line.
    Singh SV, Scalamogna D, Xia H, O'Toole S, Roy D, Emerson EO, Gupta V, Zaren HA.
    Int J Cancer; 1996 Mar 15; 65(6):852-7. PubMed ID: 8631603
    [Abstract] [Full Text] [Related]

  • 3. Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C.
    Singh SV, Xu BH, Gupta V, Emerson EO, Zaren HA, Jani JP.
    Cancer Lett; 1995 Aug 16; 95(1-2):49-56. PubMed ID: 7656243
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
    Singh SV, Xu BH, Jani JP, Emerson EO, Backes MG, Rihn C, Scalamogna D, Stemmler N, Specht S, Blanock K.
    Int J Cancer; 1995 May 04; 61(3):431-6. PubMed ID: 7729958
    [Abstract] [Full Text] [Related]

  • 5. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH, Gupta V, Singh SV.
    Arch Biochem Biophys; 1994 Jan 04; 308(1):164-70. PubMed ID: 8311448
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a BMS-181174-resistant human bladder cancer cell line.
    Xia H, Bleicher RJ, Hu X, Srivastava SK, Gupta V, Zaren HA, Singh SV.
    Br J Cancer; 1997 Jan 04; 76(4):461-6. PubMed ID: 9275022
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of differential sensitivity of human bladder cancer cells to mitomycin C and its analogue.
    Xu BH, Gupta V, Singh SV.
    Br J Cancer; 1994 Feb 04; 69(2):242-6. PubMed ID: 8297721
    [Abstract] [Full Text] [Related]

  • 8. [Mechanism of resistance to mitomycin C in a human bladder cancer cell line].
    Xu B, Sun Y, Singh SV.
    Zhonghua Zhong Liu Za Zhi; 1995 Sep 04; 17(5):343-6. PubMed ID: 8697971
    [Abstract] [Full Text] [Related]

  • 9. Biochemical mechanism of cross-resistance to paclitaxel in a mitomycin c-resistant human bladder cancer cell line.
    Bleicher RJ, Xia H, Zaren HA, Singh SV.
    Cancer Lett; 2000 Mar 31; 150(2):129-35. PubMed ID: 10704734
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of increased sensitivity to etoposide in a mitomycin C-resistant human bladder cancer cell line.
    Xia H, Bleicher RJ, Gupta V, Zaren HA, Singh SV.
    Int J Cancer; 1997 Mar 04; 70(5):606-11. PubMed ID: 9052763
    [Abstract] [Full Text] [Related]

  • 11. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
    Lambert PA, Kang Y, Greaves B, Perry RR.
    J Surg Res; 1998 Dec 04; 80(2):177-81. PubMed ID: 9878310
    [Abstract] [Full Text] [Related]

  • 12. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH, Singh SV.
    Cancer Res; 1992 Dec 01; 52(23):6666-70. PubMed ID: 1423311
    [Abstract] [Full Text] [Related]

  • 13. Modulation of mitomycin C resistance by glutathione transferase inhibitor ethacrynic acid.
    Singh SV, Xu BH, Maurya AK, Mian AM.
    Biochim Biophys Acta; 1992 Nov 17; 1137(3):257-63. PubMed ID: 1445927
    [Abstract] [Full Text] [Related]

  • 14. Isolation and characterization of a mitomycin C-resistant variant of human colon carcinoma HT-29 cells.
    Lee JH, Naito M, Nakajima M, Tsuruo T.
    Cancer Chemother Pharmacol; 1993 Nov 17; 33(3):215-20. PubMed ID: 7505723
    [Abstract] [Full Text] [Related]

  • 15. Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines.
    O'Dwyer PJ, Perez RP, Yao KS, Godwin AK, Hamilton TC.
    Biochem Pharmacol; 1996 Jul 12; 52(1):21-7. PubMed ID: 8678904
    [Abstract] [Full Text] [Related]

  • 16. Biochemical characterization of a mitomycin C resistant colon cancer cell line variant.
    Perry RR, Kang Y, Greaves B.
    Biochem Pharmacol; 1993 Dec 03; 46(11):1999-2005. PubMed ID: 7903534
    [Abstract] [Full Text] [Related]

  • 17. Decreased NADPH:cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions.
    Hoban PR, Walton MI, Robson CN, Godden J, Stratford IJ, Workman P, Harris AL, Hickson ID.
    Cancer Res; 1990 Aug 01; 50(15):4692-7. PubMed ID: 2114946
    [Abstract] [Full Text] [Related]

  • 18. Investigation of sequential mitomycin C and photodynamic therapy in a mitomycin-resistant bladder cancer cell-line model.
    French AJ, Datta SN, Allman R, Matthews PN.
    BJU Int; 2004 Jan 01; 93(1):156-61. PubMed ID: 14678389
    [Abstract] [Full Text] [Related]

  • 19. Contrasting molecular cytotoxic mechanisms of mitomycin C and its two analogs, BMY 25282 and BMY 25067, in isolated rat hepatocytes.
    Silva JM, Khan S, O'Brien PJ.
    Biochem Pharmacol; 1993 Jun 09; 45(11):2303-9. PubMed ID: 8517871
    [Abstract] [Full Text] [Related]

  • 20. Effect of treatment duration and glutathione depletion on mitomycin C cytotoxicity in vitro.
    Perry RR, Greaves BR, Rasberry U, Barranco SC.
    Cancer Res; 1992 Sep 01; 52(17):4608-12. PubMed ID: 1511428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.